Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Molecular Modelling to Help Create Better, Safer Drugs

Published: Friday, May 24, 2013
Last Updated: Friday, May 24, 2013
Bookmark and Share
How our bodies break down the common drugs ibuprofen, diclofenac and warfarin is the subject of a new study from the University of Bristol.

The research should ultimately help predict how new drugs will be metabolized in the body, potentially helping avoid adverse drug reactions in future.

Professor Adrian Mulholland of the School of Chemistry and colleagues used molecular modelling to show in atomic detail how ibuprofen, diclofenac and warfarin are broken down by a group of enzymes called cytochrome P450s which play an important part in the metabolism of drugs.

Cytochrome P450s break down drugs by adding oxygen atoms to them, thus making them more soluble in water and easier to remove from the body.  It's important that drugs are broken down in this way so they don't accumulate to toxic levels.  However, it's also important that the drugs aren't broken down too quickly otherwise they won't stay in the body long enough to work.

Different people have different types of P450 which mean they break down drugs more quickly or more slowly.  Potentially harmful complications can also sometimes occur, for example, other drugs can 'block up' P450s thus interfering with the metabolism of a particular drug.  Other substances can also interfere with the process, for example grapefruit and grapefruit juice contain a molecule that 'inhibits' some cytochrome P450s, preventing them from breaking down  drugs.  This can cause the drug to build up to a toxic – and possibly lethal – level.

Professor Mulholland said: "An important aim in developing a safe, effective drug is understanding how it will be broken down in the body.  This process would be made quicker, cheaper and safer if we could predict reliably – for example, by using computers – how a candidate drug reacts in the body.

"This study uses molecular modelling methods which are able to describe chemical reactions in large and complex enzymes such as cytochrome P450s.  Our results agree well with experiments, and point to how modelling of this sort can help in developing predictions of drug metabolism."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Human Trials of Manufactured Blood Within Two Years
The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.
Monday, June 29, 2015
Researchers to Use Algae to Clean up Mine Water
Algae will harvest the precious heavy metals and produce biofuel at the same time.
Friday, December 05, 2014
‘Switching off’ Autoimmune Diseases
Scientists have made an important breakthrough in the fight against debilitating autoimmune diseases by revealing how to stop cells attacking healthy body tissue.
Thursday, September 04, 2014
Protein Responsible for Controlling Communication Between Brain Cells Identified
Scientists are a step closer to understanding how some of the brain’s 100 billion nerve cells co-ordinate their communication.
Thursday, November 28, 2013
Manipulation of Protein Could Help Stop Spread of Cancer Cells
New findings, published in the Nature journal Oncogene, reveal how a protein, PRH, is normally able to prevent cells from unnecessary migration.
Monday, November 18, 2013
Dogs Could Act as Effective Early-Warning System for Patients with Diabetes
Dogs that are trained to respond to their owners’ hypoglycaemia could offer a very effective way to alert diabetic patients of impending lowered blood sugars.
Wednesday, August 21, 2013
Sixteen New Genetic Regions for Allergies Discovered
Regions discovered during two of the largest genetic studies ever conducted on common allergies, including pollen, dust-mite and cat allergies.
Monday, July 01, 2013
Researchers Find Key to Blood-Clotting Process
Researchers have uncovered a key process in understanding how blood clots form that could help pave the way for new therapies to reduce the risk of heart attacks.
Wednesday, June 26, 2013
Random Walks on DNA
Scientists have revealed how a bacterial enzyme has evolved an energy-efficient method to move long distances along DNA.
Monday, April 22, 2013
Major Breakthrough in Deciphering Bread Wheat's Genetic Code
UK, German and US scientists decipher complex genetic code to create new tools for breeders and researchers across the world.
Thursday, November 29, 2012
Debating the Science and Ethics of Synthetic Biology
The science and ethics of synthetic biology and what it means for the UK will be the subject of a Royal Society of Chemistry debate to be streamed live on Wednesday 14 November.
Tuesday, November 06, 2012
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!